Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UBT38006 in Healthy Adult Male Subjects
NCT07630233Phase 1Recruiting
- Start
- Jun 2026
- Primary completion
- Oct 2026
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of UBT38006 in type 2 diabetes mellitus (T2DM) (4 arms). Primary endpoint: Incidence of adverse events, adverse drug reactions, serious adverse events. Started Jun 2026; status: recruiting.
02
Drugs
UBT38006
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT07630233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07630233.